AtaiBeckley (ATAI) Stock Price, Quote, News & History | Benzinga

AtaiBeckley Inc (ATAI) Stock Price, Quote, News & History

ATAINASDAQ

Trade with Public

Trade with Public

$7.40

-0.04-0.54%

Last update: Aug 26, 9:29 AM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$7.40

Close

-

Volume / Avg.

2.86M / 11.89M

Day Range

$7.38 - $7.44

52 Wk Range

3.27 - 7.45

Market Cap

$2.74B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

72

Short Interest

5.36%

Days to Cover

2.75

Recent AtaiBeckley Inc News

This Apogee Therapeutics Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Analysts changed outlooks on top stocks. Raymond James downgraded ONON, Deutsche Bank downgraded ATAI, BTIG downgraded APGE.

Avi Kapoor

CoreWeave To Rally Around 95%? Here Are 10 Top Analyst Forecasts For Wednesday

Wall Street analysts change outlook on top names. HC Wainwright raises price target for Belite Bio, while B of A cuts Lumentum's target.

Avi Kapoor

Jim Cramer Calls This Industrial Stock ‘Sensational’ And Ameriprise Financial ‘Fantastic’

Jim Cramer praises Lockheed Martin and Ameriprise Financial, advises against Cipher Digital. Eli Lilly to acquire AtaiBeckley for $3.8B.

Avi Kapoor

Deal Dispatch: Uber Buys Delivery Hero For $14.8 Billion, Eli Lilly Acquires AtaiBeckley, Lulu’s Fashion Considers Strategic Alternatives

Deal Dispatch features companies for sale or bought — also off the block — and what bankruptcies are happening.

Caroline Ryan

This ONEOK Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday

Top Wall Street analysts changed outlook on top names. Check full changes on analyst ratings page. OKE downgraded.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-127.10M

Investing Cash Flow (TTM)

29.04M

Financing Cash Flow (TTM)

205.58M

Free Cash Flow (TTM)

-132.58M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

107.51M

Analyst Trends and Forecast

4

Mar

2

Apr

1

Jun

2

2

Jul

0

0

0

0

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.54B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

520.47

PB Ratio (TTM)

15.64

Earnings Yield % (TTM)

-37.50%

Earnings Yield % (FWD)

-5.65%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.48

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$168.81M

Debt to Equity

0.01

Issuance of Debt (TTM)

$21.81M

Repayment of Debt (TTM)

-

Key Statistics

Open

$7.40

Close

-

Volume / Avg.

2.86M / 11.89M

Day Range

$7.38 - $7.44

52 Wk Range

3.27 - 7.45

Market Cap

$2.74B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

72

Short Interest

5.36%

Days to Cover

2.75

About

Sector

Health Care

Industry

Pharmaceuticals

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebuf...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy AtaiBeckley (ATAI) stock?

A

You can purchase shares of AtaiBeckley (NASDAQ:ATAI) through any online brokerage.

View our list of the best stock brokerages

Q

Who are AtaiBeckley (ATAI) competitors?

A

Other companies in AtaiBeckley’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for AtaiBeckley (ATAI) stock?

A

AtaiBeckley has a consensus price target of $9.43.

Q

What is the current price for AtaiBeckley (ATAI)?

A

The stock price for AtaiBeckley (NASDAQ: ATAI) is $7.4 last updated August 26, 2026 at 9:29 AM EDT.

Q

Does AtaiBeckley (ATAI) pay a dividend?

A

There are no upcoming dividends for AtaiBeckley.

Q

When is AtaiBeckley (NASDAQ:ATAI) reporting earnings?

A

AtaiBeckley does not have any upcoming earnings scheduled.

Q

Is AtaiBeckley (ATAI) going to split?

A

There is no upcoming split for AtaiBeckley.

Q

What sector and industry does AtaiBeckley (ATAI) operate in?

A

AtaiBeckley is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.